Brainstorm Cell Therapeutics Inc.
BCLI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $824 | $1,644 | $187 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $80 | $106 | $67 | $63 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $423 | $585 | $621 | $135 |
| Total Curr. Assets | $508 | $1,515 | $2,332 | $385 |
| Property Plant & Equip (Net) | $617 | $826 | $1,035 | $1,241 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $182 | $184 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$253 | $225 | $22 | $22 |
| Total NC Assets | $364 | $1,051 | $1,239 | $1,447 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $872 | $2,566 | $3,571 | $1,832 |
| Liabilities | – | – | – | – |
| Payables | $6,420 | $5,997 | $6,797 | $6,080 |
| Short-Term Debt | $0 | $482 | $1,643 | $549 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,603 | $2,049 | $2,461 | $2,349 |
| Total Curr. Liab. | $9,023 | $8,528 | $10,901 | $8,978 |
| LT Debt | $376 | $95 | $127 | $171 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $447 |
| Total NC Liab. | $50 | $95 | $127 | $618 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $50 | $476 | $570 | $720 |
| Total Liabilities | $50 | $8,623 | $11,028 | $9,596 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $16 | $16 | $15 | $14 |
| Retained Earnings | -$234,509 | -$232,403 | -$229,500 | -$226,636 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $226,800 | $226,330 | $222,028 | $218,858 |
| Total Equity | $822 | -$6,057 | -$7,457 | -$7,764 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $872 | $2,566 | $3,571 | $1,832 |
| Net Debt | $371 | -$247 | $126 | $533 |